VIVALDI BIOSCIENCES INC

Profile

Company Names

VIVALDI BIOSCIENCES INC

Addresses

BELLEVUE HOSPITAL CENTER, 462 FIRST AVENUE, BLDG. A, STE. 908, NEW YORK, NY 10016

Phone Numbers

646-381-6680

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$1,974,546.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2010-07-02 
$1,974,546.00 
INDEFINITE 
INDEFINITE 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
N/A 
 
BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.P. 
PROMOTER
VIVALDI BIOSCIENCES INC
N/A 
 
BAY CITY CAPITAL FUND IV, L.P. 
PROMOTER
VIVALDI BIOSCIENCES INC
N/A 
 
DOUGLASS B. AND KIM GIVEN REVOCABLE TRUST, U/A/D 8/11/01 
PROMOTER
VIVALDI BIOSCIENCES INC
ADOLFO 
 
GARCIA-SASTRE, PH.D. 
PROMOTER
VIVALDI BIOSCIENCES INC
WILLIAM 
 
GERBER 
DIRECTOR
VIVALDI BIOSCIENCES INC   |  CONATUS PHARMACEUTICALS INC   |  ITC NEXUS HOLDING COMPANY, INC.   |  NABSYS INC   |  SYNGEN INC.
DOUGLASS 
 
GIVEN 
EXECUTIVE OFFICER, DIRECTOR
VIVALDI BIOSCIENCES INC   |  ARROWHEAD RESEARCH CORP
PETER 
 
JOHANN 
DIRECTOR
EXOSOME THERANOSTICS, INC.   |  HORIZON PHARMA, INC.   |  VIVALDI BIOSCIENCES INC   |  RESVERLOGIX CORP.   |  EXOSOME DIAGNOSTICS, INC.
ELLIOTT 
 
KIEFF, M.D. 
PROMOTER
VIVALDI BIOSCIENCES INC
DAVID 
 
LIEBOWITZ 
EXECUTIVE OFFICER, PROMOTER
VIVALDI BIOSCIENCES INC   |  VAXART, INC.   |  AROYA INVESTMENT PARTNERS, LP
GEORG 
 
NEBGEN 
DIRECTOR
ARTISAN PHARMA, INC.   |  KIKA MEDICAL INTERNATIONAL CO   |  ACT BIOTECH INC   |  EXOSOME THERANOSTICS, INC.   |  VIVALDI BIOSCIENCES INC
PETER 
 
PALESE, PH.D. 
PROMOTER
VIVALDI BIOSCIENCES INC
N/A 
 
SCHEER INVESTMENT HOLDINGS IX LLC 
PROMOTER
VIVALDI BIOSCIENCES INC
VIC 
 
SCHMITT 
DIRECTOR
VIVALDI BIOSCIENCES INC   |  SYNGEN INC.   |  XCEDE TECHNOLOGIES, INC.
WILLIAM 
O. 
WICK, JR. 
EXECUTIVE OFFICER, PROMOTER
2DEGREES MANAGEMENT CO L.P.   |  VIVALDI BIOSCIENCES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2010-07-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-07-02 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#